|

APL-5125 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Apollo Therapeutics Ltd1

Indications

  • Appendiceal Adenocarcinoma1
  • Gastric Adenocarcinoma1
  • Cholangiocarcinoma1
  • Triple Negative Breast Cancer1
  • Pancreatic Adenocarcinoma1

Duarte, California1 trial

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

City of Hope

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.